163 related articles for article (PubMed ID: 33318291)
1. Ubiquitination of MHC Class II by March-I Regulates Dendritic Cell Fitness.
Kim HJ; Bandola-Simon J; Ishido S; Wong NW; Koparde VN; Cam M; Roche PA
J Immunol; 2021 Feb; 206(3):494-504. PubMed ID: 33318291
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells.
Walseng E; Furuta K; Bosch B; Weih KA; Matsuki Y; Bakke O; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20465-70. PubMed ID: 21059907
[TBL] [Abstract][Full Text] [Related]
3. Loss of MHC II ubiquitination inhibits the activation and differentiation of CD4 T cells.
Ishikawa R; Kajikawa M; Ishido S
Int Immunol; 2014 May; 26(5):283-9. PubMed ID: 24370470
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.
Cho KJ; Walseng E; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10449-54. PubMed ID: 26240324
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
Bosch B; Heipertz EL; Drake JR; Roche PA
J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
[TBL] [Abstract][Full Text] [Related]
6. MHC Class II Ubiquitination Regulates Dendritic Cell Function and Immunity.
Wilson KR; Jenika D; Blum AB; Macri C; Xu B; Liu H; Schriek P; Schienstock D; Francis L; Makota FV; Ishido S; Mueller SN; Lahoud MH; Caminschi I; Edgington-Mitchell LE; Villadangos JA; Mintern JD
J Immunol; 2021 Nov; 207(9):2255-2264. PubMed ID: 34599081
[TBL] [Abstract][Full Text] [Related]
7.
Letendre C; Auger JP; Lemire P; Galbas T; Gottschalk M; Thibodeau J; Segura M
Front Immunol; 2018; 9():1199. PubMed ID: 29899744
[No Abstract] [Full Text] [Related]
8. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I INDUCTION REGULATES ANTIGEN PRESENTATION BY MACROPHAGES BUT NOT DENDRITIC CELLS.
Mittal SK; Cho KJ; Ishido S; Roche PA
J Biol Chem; 2015 Nov; 290(45):27158-27167. PubMed ID: 26408197
[TBL] [Abstract][Full Text] [Related]
10. Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.
Yang H; Qiu Q; Gao B; Kong S; Lin Z; Fang D
J Exp Med; 2014 Nov; 211(12):2467-79. PubMed ID: 25366967
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism.
Chattopadhyay G; Shevach EM
J Immunol; 2013 Dec; 191(12):5875-84. PubMed ID: 24218453
[TBL] [Abstract][Full Text] [Related]
12. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells.
Young LJ; Wilson NS; Schnorrer P; Proietto A; ten Broeke T; Matsuki Y; Mount AM; Belz GT; O'Keeffe M; Ohmura-Hoshino M; Ishido S; Stoorvogel W; Heath WR; Shortman K; Villadangos JA
Nat Immunol; 2008 Nov; 9(11):1244-52. PubMed ID: 18849989
[TBL] [Abstract][Full Text] [Related]
13. Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.
Cho KJ; Ishido S; Eisenlohr LC; Roche PA
J Immunol; 2020 Mar; 204(6):1621-1629. PubMed ID: 31996461
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells.
Ohmura-Hoshino M; Matsuki Y; Mito-Yoshida M; Goto E; Aoki-Kawasumi M; Nakayama M; Ohara O; Ishido S
J Immunol; 2009 Dec; 183(11):6893-7. PubMed ID: 19917682
[TBL] [Abstract][Full Text] [Related]
15. FcRγ-chain ITAM signaling is critically required for cross-presentation of soluble antibody-antigen complexes by dendritic cells.
Boross P; van Montfoort N; Stapels DA; van der Poel CE; Bertens C; Meeldijk J; Jansen JH; Verbeek JS; Ossendorp F; Wubbolts R; Leusen JH
J Immunol; 2014 Dec; 193(11):5506-14. PubMed ID: 25355925
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitination of MHC Class II Is Required for Development of Regulatory but Not Conventional CD4
Liu H; Wilson KR; Schriek P; Macri C; Blum AB; Francis L; Heinlein M; Nataraja C; Harris J; Jones SA; Gray DHD; Villadangos JA; Mintern JD
J Immunol; 2020 Sep; 205(5):1207-1216. PubMed ID: 32747505
[TBL] [Abstract][Full Text] [Related]
17. MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway.
Wilson KR; Liu H; Healey G; Vuong V; Ishido S; Herold MJ; Villadangos JA; Mintern JD
PLoS One; 2018; 13(7):e0200540. PubMed ID: 30001419
[TBL] [Abstract][Full Text] [Related]
18. A major isoform of the E3 ubiquitin ligase March-I in antigen-presenting cells has regulatory sequences within its gene.
Kaul S; Mittal SK; Roche PA
J Biol Chem; 2018 Mar; 293(12):4478-4485. PubMed ID: 29378848
[TBL] [Abstract][Full Text] [Related]
19. CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells.
Rocha-Perugini V; Martínez Del Hoyo G; González-Granado JM; Ramírez-Huesca M; Zorita V; Rubinstein E; Boucheix C; Sánchez-Madrid F
Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28533221
[TBL] [Abstract][Full Text] [Related]
20. MARCH-I: A negative regulator of dendritic cell maturation.
Valizadeh M; Raoofian R; Homayoonfar A; Hajati E; Pourfathollah AA
Exp Cell Res; 2024 Mar; 436(1):113946. PubMed ID: 38331309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]